RUNX1 and myeloid neoplasm: The two neoantigens recognizing T cells identified in this study resulted both from a well-characterized driver gene in myeloid neoplasms (RUNX1; patient DD30) and from a mutation in AP3S1 gene (patient DD31) not known for its role in pathogenesis, which suggests that neoantigens can arise from both driven and passenger mutations in this malignancy.